Юридически обязательной является английская версия.
iGluPal Terms of Use
Last updated: 18 November 2026
These terms apply to the iGluPal app ("the app"), made by Furkan Özoğlu. By using the app you agree to them.
Licence
The app is licensed to you under Apple's Standard End User License Agreement, which is part of these terms.
Not a medical device
- iGluPal is a diary for the values you enter. It does not measure blood sugar and does not diagnose, treat or prevent any condition.
- The estimated HbA1c is a calculation from your own entries and can differ from a lab result. Charts and statistics depend on what you enter.
- Do not change your treatment because of the app. Talk to your doctor about your readings and your health.
iGluPal Pro
- iGluPal Pro is an auto-renewing monthly or yearly subscription. The price is shown in the app before you buy.
- Payment is charged to your Apple Account when you confirm the purchase.
- The subscription renews automatically unless auto-renew is turned off at least 24 hours before the end of the current period.
- You can manage or cancel it in your App Store account settings. Refunds are handled by Apple.
Your data
Your readings are stored on your device. Keep your own copy (for example a PDF or CSV export) if they matter to you; deleting the app deletes them.
Liability
The app is provided "as is". To the extent the law allows, we are not liable for any loss or damage that results from using the app or its calculations. Nothing in these terms limits rights you have under consumer protection law.
Changes
We may change the app, its features and these terms. The date above shows the latest version.
Contact
Furkan Özoğlu, fozodev@gmail.com. How we handle your data is described in the Privacy Policy.